M. Osborne

Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice.

B. Monia, Pengxiang She, S. Bhanot, 2004, Diabetes.

Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats.

J. Olefsky, J. Wilkes, K. Demarest, 2005, American journal of physiology. Endocrinology and metabolism.

Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice.

B. Monia, Pengxiang She, S. Bhanot, 2005, Metabolism: clinical and experimental.

Topiramate ameliorates hyperglycaemia and improves glucose‐stimulated insulin release in ZDF rats and db/db mice

X. Chen, K. Demarest, T. Jetton, 2005, Diabetes, obesity & metabolism.

In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease.

K. Rhodes, B. Shook, Xun Li, 2010, Journal of medicinal chemistry.

Benzoxazinones as PPARgamma agonists. 2. SAR of the amide substituent and in vivo results in a type 2 diabetes model.

T. Burris, K. Demarest, P. Rybczynski, 2004, Journal of medicinal chemistry.

Pharmacological profile of a novel, non‐TZD PPARγ agonist

X. Chen, K. Demarest, E. Cryan, 2005 .

A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.

T. Burris, K. Demarest, L. Zhou, 1999, Molecular endocrinology.